OLA1
Basic information
Region (hg38): 2:174072447-174248599
Previous symbols: [ "GTPBP9" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the OLA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 0 | 0 |
Variants in OLA1
This is a list of pathogenic ClinVar variants found in the OLA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-174075472-A-G | not specified | Uncertain significance (Sep 07, 2022) | ||
2-174078985-A-T | not specified | Uncertain significance (Apr 12, 2023) | ||
2-174081168-C-T | not specified | Uncertain significance (Apr 12, 2024) | ||
2-174081219-A-T | not specified | Uncertain significance (Mar 30, 2024) | ||
2-174081927-T-C | not specified | Uncertain significance (Aug 02, 2022) | ||
2-174081939-G-T | not specified | Uncertain significance (Mar 30, 2024) | ||
2-174081941-T-G | not specified | Uncertain significance (Mar 20, 2023) | ||
2-174081957-C-T | not specified | Uncertain significance (Mar 30, 2024) | ||
2-174081973-A-T | not specified | Uncertain significance (Mar 30, 2024) | ||
2-174081974-T-A | not specified | Uncertain significance (Mar 30, 2024) | ||
2-174082006-A-C | Malignant tumor of prostate | Uncertain significance (-) | ||
2-174082017-A-G | not specified | Uncertain significance (Feb 06, 2023) | ||
2-174082027-G-A | not specified | Uncertain significance (Jun 30, 2022) | ||
2-174082033-A-G | not specified | Uncertain significance (Mar 30, 2024) | ||
2-174123617-T-C | not specified | Uncertain significance (Jun 21, 2023) | ||
2-174123669-T-G | not specified | Uncertain significance (Jan 30, 2024) | ||
2-174141892-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
2-174141940-A-G | not specified | Uncertain significance (Oct 12, 2022) | ||
2-174223040-A-T | not specified | Uncertain significance (Dec 15, 2023) | ||
2-174223105-G-A | not specified | Uncertain significance (Aug 02, 2022) | ||
2-174223107-G-A | not specified | Uncertain significance (Jun 06, 2023) | ||
2-174229354-G-A | not specified | Uncertain significance (Jul 21, 2021) | ||
2-174246742-A-G | not specified | Uncertain significance (Jun 17, 2024) | ||
2-174246778-G-A | not specified | Uncertain significance (Jul 05, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
OLA1 | protein_coding | protein_coding | ENST00000284719 | 10 | 176252 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0581 | 0.941 | 125726 | 0 | 13 | 125739 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.75 | 131 | 201 | 0.652 | 0.00000946 | 2632 |
Missense in Polyphen | 37 | 75.411 | 0.49064 | 1041 | ||
Synonymous | -0.674 | 74 | 67.0 | 1.10 | 0.00000329 | 698 |
Loss of Function | 2.98 | 6 | 20.6 | 0.292 | 0.00000103 | 268 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000645 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000569 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000648 | 0.0000615 |
Middle Eastern | 0.0000569 | 0.0000544 |
South Asian | 0.000141 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes ATP, and can also hydrolyze GTP with lower efficiency. Has lower affinity for GTP. {ECO:0000255|HAMAP- Rule:MF_03167}.;
- Pathway
- Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.253
Intolerance Scores
- loftool
- 0.448
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 37.11
Haploinsufficiency Scores
- pHI
- 0.529
- hipred
- Y
- hipred_score
- 0.528
- ghis
- 0.610
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ola1
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; respiratory system phenotype; liver/biliary system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Gene ontology
- Biological process
- platelet degranulation;ATP metabolic process
- Cellular component
- extracellular region;nucleolus;cytoplasm;centrosome;cytosol;membrane;platelet alpha granule lumen;extracellular exosome
- Molecular function
- protein binding;ATP binding;GTP binding;ATPase activity;ribosome binding;ribosomal large subunit binding;cadherin binding;metal ion binding